Clinical Statements
BTS Clinical Statements provide a snapshot of knowledge and best practice in a topical clinical area and include a series of clinical practice points. Read the Clinical Statement Production Manual 2025.
Declarations of Interest
All members of BTS Clinical Statement Groups adhere to the BTS Policy for Working with the Biomedical Industry and complete an annual declaration of interest during the period that the clinical statement group is active. For more information please contact: bts@brit-thoracic.org.uk.
Filter by:
| A-Z Disease / Topic | Clinical Statement title | Publication date | Description | |
|---|---|---|---|---|
| Air Travel for passengers with respiratory disease | BTS Clinical Statement on Air Travel for Passengers with Respiratory Disease | 20220301 March 2022 | Covers pre-flights screening and detailed recommendations for many respiratory conditions. | READ MORE |
| Aspergillus-related chronic lung disease | BTS Clinical Statement on Aspergillus-related chronic pulmonary disease | 20250501 May 2025 | Covers diagnosis, management and use of antifungal therapy. | READ MORE |
| Aspiration Pneumonia | BTS Clinical Statement on aspiration pneumonia | 20230301 March 2023 | Covers epidemiology, pathogenesis, prevention, diagnosis and management. | READ MORE |
| Athletic individuals | BTS Clinical Statement on Assessment and Management of Respiratory Problems in Athletic Individuals | 20220401 April 2022 | Diagnosis, evaluation and management of respiratory problems in athletic individuals. | READ MORE |
| CAP in people with learning disability | BTS Clinical Statement on CAP in people with learning disability | 20230301 March 2023 | This statement covers risk assessment, prevention and management of community-acquired pneumonia in people with a learning disability of all ages. | READ MORE |
| Chronic Cough in Adults | Chronic Cough in Adults | 20231201 December 2023 | BTS Clinical Statement on chronic cough in adults. Covers assessment, treatment, complications and research. | READ MORE |
| COPD and Biologic Therapies | COPD and Biologic Therapies | 20260901 September 2026 | This statement is under development and due to be published later in 2026 | READ MORE |
| Cough in Children | Cough in children | 20260901 September 2026 | This statement is under development and due to be published later in 2026 | READ MORE |
| MDR-TB | BTS Clinical Statement on the Management of Multidrug-Resistant Tuberculosis (MDRTB) | 20161101 November 2016 | Clinical Statement on the Management of MDRTB | READ MORE |
| Tobacco Dependency | BTS Clinical Statement on medical management of inpatients with tobacco dependency | 20240301 March 2024 | Key clinical practice points about screening, providing advice about smoking and vaping, use of NRT and referral to on-site tobacco dependency advisor. | READ MORE |
| Occupational Asthma | BTS Clinical Statement on Occupational Asthma | 20220301 March 2022 | Clinical Statement on Occupational Asthma | READ MORE |
| Ocular TB | BTS Clinical Statement for the diagnosis and management of ocular tuberculosis | 20220401 April 2022 | BTS Clinical Statement on Ocular TB, for Respiratory, Infectious Disease and Ophthalmic specialists. Covers diagnosis and management of OTB in adults. | READ MORE |
| PAVM | BTS Clinical Statement on Pulmonary Arteriovenous Malformations (PAVMs) | 20171101 November 2017 | The statement covers the management of PAVMs already known to be present, screening, diagnosis and follow-up. | READ MORE |
| Pleural Procedures | BTS Clinical Statement on Pleural Procedures | 20230701 July 2023 | BTS Clinical Statement on Pleural Procedures | READ MORE |
| Pulmonary Rehabilitation | Pulmonary Rehabilitation | 20230901 September 2023 | Clinical Statement on pulmonary rehabilitation in COPD and other respiratory conditions | READ MORE |
| Sarcoidosis | BTS Sarcoidosis Clinical Statement | 20201201 December 2020 | BTS Clinical Statement on pulmonary sarcoidosis. Covers diagnosis, evaluation and management. | READ MORE |
| Silicosis | Silicosis | 20261101 November 2026 | This statement is under development and due to be published later in 2026 | READ MORE |
